Artificial Pancreas Device Systems Market By Type (Threshold Suspend Device System, Control-to-Range (CTR) System, Control-to-Target (CTT) System) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global artificial pancreas device systems (APDS) studies the overall market scenario, the ongoing trends, future commercial prospects and the competition in the artificial pancreas device systems market. For the purpose of this study, the global artificial pancreas device systems market is studied for device type and geographical distribution. This study estimates the future prospects of the APDS, post introduction of certain target devices in the diabetes market. It is to be noted that the APDS thus described do not involve biomaterial, synthetic or artificial tissue or organs and bionic substitutes.

Based on device types, the global artificial pancreas device systems market is categorized into threshold suspended device systems, control-to-range (CTR) systems, control-to-target (CTT) systems segments. The market estimates in terms of revenue forecast for each of these segments since their product launch until the year 2022 are provided in this study, along with their respective CAGRs for the corresponding periods through 2022.

The artificial pancreas device systems market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, and Japan. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

Apart from the quantitative information, this report includes qualitative information sets such as drivers, challenges and opportunities, market inclination insights, major commercial events, device mechanism of artificial pancreas device systems, and benefits to the stakeholders in this market. This report also includes tools such as attractive investment proposition, Porter’s Five Forces model and market positioning of key players to assess the overall market competition. This report concludes with profiles of certain market players that have a foothold in the global diabetes management and consequently prospective pipeline in the artificial pancreas device systems market.

The major key players profiled in the artificial pancreas device systems market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The major players profiled in this report include Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., and JDRF.

For the purpose of this study, the global artificial pancreas device systems market is categorized as follows:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

The geographical segmentation of the global market for artificial pancreas device systems market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In base year 2015, North America accounted for the largest market in the artificial pancreas device systems market due to large scale research and academic studies being conducted in U.S. for further exploring the perfect design of artificial pancreas is expected to majorly drive the North America artificial pancreas device market. 

The major key players are based in North America which is also considered as an added advantage. Asia Pacific and Latin America is expected to project highest growth after 2022 as the cost of artificial pancreas devices and systems are predicted to be high and most of the low income countries from these regions will be difficult to penetrate with it. However, the artificial pancreas device systems market is expected to achieve maturity by 2022 which would intensify the market competition, revamp of pricing strategies, and emphasis on geographical expansion and penetration. Thus, artificial pancreas device systems market in Asia Pacific and Latin America is expected to grow at exceptional rate after 2022.